AUMED a.s. was established in 2007 and is now mainly engaged in research and development.. Its original focus has gradually begun to focus on the healthcare and pharmaceutical industries, where research and development activities are absolutely necessary due to new market requirements. The company AUMED, a.s. is also the sole shareholder of AUMED Immunology a.s.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
You can adjust all of your cookie settings by navigating the tabs on the left hand side.